Total Reports
28
FDA CVM filings
Dog /
FDA CVM · 2025 release 28 reports on file
Sheepdog - Maremma and Abruzzes - FDA Adverse Event Profile
Adverse-event records for Sheepdog - Maremma and Abruzzes (Dog) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
With 28 reports on file, Sheepdog - Maremma and Abruzzes sits at #326 among dog breeds by volume; death-coded share is 0.0% (0 reports).
- #326
- most-reported dog breed
- 0.0%
- death-coded report share
- 7
- Lack of efficacy (endoparasite) - heartworm - top reaction
- 3.8 yr
- average age at report
Higher volume usually means a more popular breed, not a riskier one, compare against how common the breed is.
Deaths Reported
0
of 28 reports
Death Rate
0.0%
death-coded share
Avg Age at Report
3.8 yr
41.0 kg avg weight
Death-Coded Outcome Share
Sheepdog - Maremma and Abruzzes death-coded reports 0.0%
Cross-breed median
0.0% of 28 sheepdog - maremma and abruzzes reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 41.0 kg (90.4 lbs)
Top Reported Reactions
Lack of efficacy (endoparasite) - heartworm 7
Lack of efficacy (bacteria) - Borrelia 4
Lethargy (see also Central nervous system depression in 'Neurological') 2
Scratching 2
Panting 2
Most Referenced Drugs
Pyrantel Pamoate;Sarolaner 6
Milbemycin Oxime + Spinosad 3
Oclacitinib Maleate 3
Ivermectin + Pyrantel As Pamoate Salt 3
Moxidectin 3
Outcome Breakdown
Ongoing
16 (57.1%)
Recovered/Normal
5 (17.9%)
Outcome Unknown
5 (17.9%)
Recovered with Sequela
2 (7.1%)
Gender Distribution
Male 20 (71.4%)
Female 8 (28.6%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2014 | 1 | |
| 2015 | 1 | |
| 2016 | 1 | |
| 2017 | 1 | |
| 2018 | 1 | |
| 2019 | 3 | |
| 2020 | 1 | |
| 2021 | 5 | |
| 2022 | 5 | |
| 2023 | 3 | |
| 2024 | 4 | |
| 2025 | 2 | |
Sheepdog - Maremma and Abruzzes Pet Health Insights
Sheepdog - Maremma and Abruzzes accounts for 28 FDA adverse event reports, ranking #326 by volume among dog breeds, with 0 reports (0.0%) coded as a death outcome. Mean age at report: 3.8 years, average weight 41.0 kg (90.4 lbs).
Top reported signs: Lack of efficacy (endoparasite) - heartworm (7), Lack of efficacy (bacteria) - Borrelia (4), Lethargy (see also Central nervous system depression in 'Neurological') (2). Most-referenced drug: Pyrantel Pamoate;Sarolaner (6 reports), followed by Milbemycin Oxime + Spinosad (3) and Oclacitinib Maleate (3).
Outcome coding on 28 status-recorded reports is dominated by Ongoing (57.1%). Annual submissions ranged 2,014-2,025 across 12 years on file.
Dog Breeds With a Similar Report Volume
Basset - Griffon Vendeen Small
28 reports · 7.1% death rate
Mastiff - Tibetan
28 reports · 7.1% death rate
Terrier - Black Russian
28 reports · 0.0% death rate
Terrier - Skye
28 reports · 3.6% death rate
Deerhound - scottish
29 reports · 20.7% death rate
Terrier - Dandie Dinmont
27 reports · 3.7% death rate
Frequently Asked Questions
How many FDA adverse event reports involve Sheepdog - Maremma and Abruzzes? ▼
There are 28 adverse event reports involving Sheepdog - Maremma and Abruzzes in the FDA database, with 0 reports involving death (0.0% death rate). Sheepdog - Maremma and Abruzzes ranks #326 by report volume.
What are the most common adverse reactions reported for Sheepdog - Maremma and Abruzzes? ▼
The most commonly reported adverse reactions for Sheepdog - Maremma and Abruzzes are Lack of efficacy (endoparasite) - heartworm (7 reports), Lack of efficacy (bacteria) - Borrelia (4 reports), Lethargy (see also Central nervous system depression in 'Neurological') (2 reports), Scratching (2 reports), Panting (2 reports).
What drugs are most frequently associated with Sheepdog - Maremma and Abruzzes adverse events? ▼
The drugs most frequently referenced in Sheepdog - Maremma and Abruzzes adverse event reports are Pyrantel Pamoate;Sarolaner (6 reports), Milbemycin Oxime + Spinosad (3 reports), Oclacitinib Maleate (3 reports), Ivermectin + Pyrantel As Pamoate Salt (3 reports), Moxidectin (3 reports).
What is the average age of Sheepdog - Maremma and Abruzzes in adverse event reports? ▼
The average age of Sheepdog - Maremma and Abruzzes at the time of adverse event reports is 3.8 years, with an average weight of 41.0 kg (90.4 lbs).
Does a high number of adverse event reports mean Sheepdog - Maremma and Abruzzes is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Sheepdog - Maremma and Abruzzes safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.